Non-Invasive Prenatal Testing Market Size, Share, Trends, Industry Analysis Report: By Gestation Period, Component, Method, Application, End Use, and Region

Description

List of Tables

The non-invasive prenatal testing market size is expected to reach USD 11.39 billion by 2034, according to a new study by Polaris Market Research. The report "Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Trends, Industry Analysis Report: By Gestation Period (0-12 Weeks, 13-24 Weeks, and 25-36 Weeks), Component, Method, Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Non-invasive prenatal testing (NIPT) refers to a method used to screen for certain genetic conditions in a fetus, such as Down syndrome, using a blood sample from the pregnant individual. This test analyzes small fragments of fetal DNA that are circulating in the maternal blood. It is a preferred option among users for its accuracy and safety compared to invasive methods.

The growing importance of early detection of genetic disorders is a primary driver for the NIPT market. Significant advancements in genomic technology and bioinformatics have propelled the NIPT market. Improvements in next-generation sequencing (NGS) technology have enhanced the accuracy and efficiency of fetal DNA analysis. These technological innovations have led to more affordable and accessible NIPT options, thereby expanding its adoption among healthcare providers and patients. For instance, in May 2021, Illumina, Inc. and Next Generation Genomic Co., Ltd. announced the launch of VeriSeq NIPT Solution v2, a CE-IVD, NGS-based approach to NIPT. As technology continues to evolve, it is expected to improve the capabilities and affordability of NIPT further.

The non-invasive prenatal testing market is driven by intense competition with strategies including price competitiveness and technological innovation with strategic partnerships. For instance, in July 2021, Pacific Biosciences of California, Inc. announced the acquisition of Omniome. With the acquisition, Pacific Biosciences will be able to expand the market opportunity for sequencing in creative ways that benefit customers. Through its innovative methodology, Omniome aims to provide an accurate short-read sequencing platform to enable it to enter rapidly expanding clinical application areas such as non-invasive prenatal testing and oncology.

Additionaly, in October 2024, Yourgene Health installed the first non-invasive prenatal testing (NIPT) workflow in Colombia at Genetix. The service will deliver fast, precise NIPT results for expectant parents in Colombia, serving to reduce turnaround times and delivery problems.

Non-Invasive Prenatal Testing (NIPT) Market Report Highlights

By method analysis, the cell-free DNA in maternal plasma tests segment dominated the market in 2024, mainly attributed to its minimal risk and superior accuracy compared to traditional invasive methods.

By application analysis, the trisomy segment dominated the market in 2024 owing to NIPT's role in detecting common chromosomal abnormalities such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome).

North America dominated the market in 2024 due to advanced healthcare infrastructure, high awareness levels, and robust adoption of advanced technologies.

Asia Pacific is expected to register the fastest CAGR, owing to economic growth, technological innovation, geographic expansion, and strategic partnerships.

The key market players include Agilent Technologies, Inc.; Centogene N.V.; Eurofins LifeCodexx GmbH; F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics); Illumina, Inc.; Laboratory Corp. of America Holdings; MedGenome Labs Ltd.; Myriad Women's Health, Inc.; Natera, Inc.; Progenity, Inc.; Qiagen; Quest Diagnostics, Inc.; and Thermo Fisher Scientific, Inc.

Polaris Market Research has segmented the non-invasive prenatal testing market report based on gestation period, component, method, application, end use, and region:

By Gestation Period Outlook (Revenue - USD Billion, 2020-2034)

0-12 weeks
13-24 weeks
25-36 weeks

By Component Outlook (Revenue - USD Billion, 2020-2034)

Consumables
Instruments
Software
Services

By Method Outlook (Revenue - USD Billion, 2020-2034)

Cell-Free DNA in Maternal Plasma Tests
Ultrasound Detection
Biochemical Screening Tests
Others

By Application Outlook (Revenue - USD Billion, 2020-2034)

Monosomy
Trisomy
Microdeletion Syndrome
Others

By End-Use Outlook (Revenue - USD Billion, 2020-2034)

Diagnostic Centers
Hospitals and Clinics
Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Australia
Malaysia
Vietnam
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of the Middle East & Africa

Product Code: PM1836

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Non-Invasive Prenatal Testing (NIPT) Market Insights

4.1. Non-Invasive Prenatal Testing (NIPT) Market - Application Snapshot
4.2. Non-Invasive Prenatal Testing (NIPT) Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising technological advancements in sequencing technologies and bioinformatics
  - 4.2.1.2. Rise in Maternal Age
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Application of NIPT for sex selection on non-medical backgrounds is prohibited in some countries.
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Non-Invasive Prenatal Testing (NIPT) Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
5.3. 0-12 weeks
- 5.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 0-12 weeks, by Region, 2020-2034 (USD Billion)
5.4. 13-24 weeks
- 5.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 13-24 weeks, by Region, 2020-2034 (USD Billion)
5.5. 25-36 weeks
- 5.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 25-36 weeks, by Region, 2020-2034 (USD Billion)

6. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
6.3. Consumables
- 6.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Consumables, by Region, 2020-2034 (USD Billion)
6.4. Instruments
- 6.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Instruments, by Region, 2020-2034 (USD Billion)
6.5. Software
- 6.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Software, by Region, 2020-2034 (USD Billion)
6.6. Services
- 6.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Services, by Region, 2020-2034 (USD Billion)

7. Global Non-Invasive Prenatal Testing (NIPT) Market, by Method

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
7.3. Cell-Free DNA in Maternal Plasma Tests
- 7.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Cell-Free DNA in Maternal Plasma Tests, by Region, 2020-2034 (USD Billion)
7.4. Ultrasound Detection
- 7.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Ultrasound Detection, by Region, 2020-2034 (USD Billion)
7.5. Biochemical Screening Tests
- 7.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Biochemical Screening Tests, by Region, 2020-2034 (USD Billion)
7.6. Others
- 7.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
8.3. Monosomy
- 8.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Monosomy, by Region, 2020-2034 (USD Billion)
8.4. Trisomy
- 8.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Trisomy, by Region, 2020-2034 (USD Billion)
8.5. Microdeletion Syndrome
- 8.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Microdeletion Syndrome, by Region, 2020-2034 (USD Billion)
8.6. Other
- 8.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Other, by Region, 2020-2034 (USD Billion)

9. Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
9.3. Diagnostic Centers
- 9.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
9.4. Hospitals and Clinics
- 9.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Billion)

10. Global Non-Invasive Prenatal Testing (NIPT) Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2020-2034 (USD Billion)
10.3. Non-Invasive Prenatal Testing (NIPT) Market - North America
- 10.3.1. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
- 10.3.2. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
- 10.3.3. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
- 10.3.4. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
- 10.3.5. North America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.3.7. Non-Invasive Prenatal Testing (NIPT) Market - U.S.
  - 10.3.7.1. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.3.7.2. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.3.7.3. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.3.7.4. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.3.7.5. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.3.8. Non-Invasive Prenatal Testing (NIPT) Market - Canada
  - 10.3.8.1. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.3.8.2. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.3.8.3. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.3.8.4. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.3.8.5. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
10.4. Non-Invasive Prenatal Testing (NIPT) Market - Europe
- 10.4.1. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
- 10.4.2. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
- 10.4.3. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
- 10.4.4. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
- 10.4.5. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.6. Non-Invasive Prenatal Testing (NIPT) Market - UK
  - 10.4.6.1. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.6.2. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.6.3. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.6.4. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.6.5. UK: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.7. Non-Invasive Prenatal Testing (NIPT) Market - France
  - 10.4.7.1. France: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.7.2. France: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.7.3. France: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.7.4. France: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.7.5. France: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.8. Non-Invasive Prenatal Testing (NIPT) Market - Germany
  - 10.4.8.1. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.8.2. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.8.3. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.8.4. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.8.5. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.9. Non-Invasive Prenatal Testing (NIPT) Market - Italy
  - 10.4.9.1. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.9.2. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.9.3. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.9.4. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.9.5. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.10. Non-Invasive Prenatal Testing (NIPT) Market - Spain
  - 10.4.10.1. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.10.2. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.10.3. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.10.4. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.10.5. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.11. Non-Invasive Prenatal Testing (NIPT) Market - Netherlands
  - 10.4.11.1. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.11.2. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.11.3. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.11.4. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.11.5. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.12. Non-Invasive Prenatal Testing (NIPT) Market - Russia
  - 10.4.12.1. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.12.2. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.12.3. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.12.4. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.12.5. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.13. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.13.2. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.13.3. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.13.4. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.13.5. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
10.5. Non-Invasive Prenatal Testing (NIPT) Market - Asia Pacific
- 10.5.1. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.6. Non-Invasive Prenatal Testing (NIPT) Market - China
  - 10.5.6.1. China: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.6.2. China: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.6.3. China: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.6.4. China: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.6.5. China: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.7. Non-Invasive Prenatal Testing (NIPT) Market - India
  - 10.5.7.1. India: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.7.2. India: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.7.3. India: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.7.4. India: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.7.5. India: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.8. Non-Invasive Prenatal Testing (NIPT) Market - Malaysia
  - 10.5.8.1. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.8.2. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.8.3. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.8.4. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.8.5. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.9. Non-Invasive Prenatal Testing (NIPT) Market - Japan
  - 10.5.9.1. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.9.2. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.9.3. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.9.4. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.9.5. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.10. Non-Invasive Prenatal Testing (NIPT) Market - Indonesia
  - 10.5.10.1. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.10.2. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.10.3. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.10.4. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.10.5. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.11. Non-Invasive Prenatal Testing (NIPT) Market - South Korea
  - 10.5.11.1. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.11.2. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.11.3. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.11.4. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.11.5. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.12. Non-Invasive Prenatal Testing (NIPT) Market - Australia
  - 10.5.12.1. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.12.2. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.12.3. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.12.4. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.12.5. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.13. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.13.2. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.13.3. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.13.4. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.13.5. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
10.6. Non-Invasive Prenatal Testing (NIPT) Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.6.6. Non-Invasive Prenatal Testing (NIPT) Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.6.6.2. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.6.6.3. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.6.6.4. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.6.6.5. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.6.7. Non-Invasive Prenatal Testing (NIPT) Market - UAE
  - 10.6.7.1. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.6.7.2. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.6.7.3. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.6.7.4. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.6.7.5. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.6.8. Non-Invasive Prenatal Testing (NIPT) Market - Israel
  - 10.6.8.1. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.6.8.2. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.6.8.3. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.6.8.4. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.6.8.5. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.6.9. Non-Invasive Prenatal Testing (NIPT) Market - South Africa
  - 10.6.9.1. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.6.9.2. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.6.9.3. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.6.9.4. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.6.9.5. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.6.10. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.6.10.2. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.6.10.3. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.6.10.4. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.6.10.5. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
10.7. Non-Invasive Prenatal Testing (NIPT) Market - Latin America
- 10.7.1. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.7.6. Non-Invasive Prenatal Testing (NIPT) Market - Mexico
  - 10.7.6.1. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.7.6.2. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.7.6.3. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.7.6.4. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.7.6.5. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.7.7. Non-Invasive Prenatal Testing (NIPT) Market - Brazil
  - 10.7.7.1. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.7.7.2. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.7.7.3. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.7.7.4. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.7.7.5. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.7.8. Non-Invasive Prenatal Testing (NIPT) Market - Argentina
  - 10.7.8.1. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.7.8.2. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.7.8.3. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.7.8.4. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.7.8.5. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.7.9. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.7.9.2. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.7.9.3. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.7.9.4. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.7.9.5. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Agilent Technologies, Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Centogene N.V
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Eurofins LifeCodexx GmbH
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. F; Hoffmann-La Roche Ltd
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. Illumina, Inc
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Laboratory Corp. of America Holdings
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. MedGenome Labs Ltd
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Myriad Women's Health, Inc.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Natera, Inc.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Progenity, Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. Qiagen
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
12.12. Quest Diagnostics, Inc.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
12.13. Thermo Fisher Scientific, Inc.
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development